Anesthetic management of transcatheter aortic valve implantation

Research output: Contribution to journalArticle

Abstract

Purpose of Review: The revolution in transcatheter aortic valve implantation (TAVI) for the treatment of aortic stenosis has been well described by the large number of randomized trials, registries, and single and multicenter experiences published during 2010-2011. The aim of this review is to describe the challenges of the anesthetic management related to TAVI. Recent Findings: Recent data show that TAVI is clinically effective in patients with inoperable aortic stenosis when compared with standard therapy. It can be accomplished in high-risk patients with favorable outcomes compared with surgery as predicted by standard estimates of mortality and is associated with functional and hemodynamic improvement. Currently, TAVI is targeted at high-risk patients, but may be extended to lower risk groups in the near future. Outstanding questions concerning TAVI are related to its long-term durability and to procedural complications. Summary: Preprocedural, multidisciplinary assessment of the patient is essential prior to TAVI and should include a full anesthetic evaluation, consideration of patient comorbidities, and determination of technical feasibility. The role of scoring systems for risk prediction requires further scrutiny. Multidevice/multiple access approaches allow for treatment of a wide range of patients. Anesthetic techniques and supportive measures vary depending on procedural concerns, patient comorbidity, and severe, often unstable cardiac disease. Echocardiography is fundamental to preoperative evaluation, procedure guidance, and assessment of complications. Planned bailout strategies should be discussed with all members of the medical team. Postoperative standardized monitoring and management protocols are essential.

Original languageEnglish
Pages (from-to)417-425
Number of pages9
JournalCurrent Opinion in Anaesthesiology
Volume24
Issue number4
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Anesthetics
Aortic Valve Stenosis
Comorbidity
Preoperative Care
Transcatheter Aortic Valve Replacement
Registries
Echocardiography
Heart Diseases
Therapeutics
Hemodynamics
Mortality

Keywords

  • anesthesia
  • aortic stenosis
  • complications
  • transcatheter aortic valve implantation
  • transesophageal echocardiography

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Anesthetic management of transcatheter aortic valve implantation. / Covello, Remo D.; Landoni, Giovanni; Zangrillo, Alberto.

In: Current Opinion in Anaesthesiology, Vol. 24, No. 4, 08.2011, p. 417-425.

Research output: Contribution to journalArticle

@article{b4efb38c92e04a4b8fe29d3572562909,
title = "Anesthetic management of transcatheter aortic valve implantation",
abstract = "Purpose of Review: The revolution in transcatheter aortic valve implantation (TAVI) for the treatment of aortic stenosis has been well described by the large number of randomized trials, registries, and single and multicenter experiences published during 2010-2011. The aim of this review is to describe the challenges of the anesthetic management related to TAVI. Recent Findings: Recent data show that TAVI is clinically effective in patients with inoperable aortic stenosis when compared with standard therapy. It can be accomplished in high-risk patients with favorable outcomes compared with surgery as predicted by standard estimates of mortality and is associated with functional and hemodynamic improvement. Currently, TAVI is targeted at high-risk patients, but may be extended to lower risk groups in the near future. Outstanding questions concerning TAVI are related to its long-term durability and to procedural complications. Summary: Preprocedural, multidisciplinary assessment of the patient is essential prior to TAVI and should include a full anesthetic evaluation, consideration of patient comorbidities, and determination of technical feasibility. The role of scoring systems for risk prediction requires further scrutiny. Multidevice/multiple access approaches allow for treatment of a wide range of patients. Anesthetic techniques and supportive measures vary depending on procedural concerns, patient comorbidity, and severe, often unstable cardiac disease. Echocardiography is fundamental to preoperative evaluation, procedure guidance, and assessment of complications. Planned bailout strategies should be discussed with all members of the medical team. Postoperative standardized monitoring and management protocols are essential.",
keywords = "anesthesia, aortic stenosis, complications, transcatheter aortic valve implantation, transesophageal echocardiography",
author = "Covello, {Remo D.} and Giovanni Landoni and Alberto Zangrillo",
year = "2011",
month = "8",
doi = "10.1097/ACO.0b013e328347f99f",
language = "English",
volume = "24",
pages = "417--425",
journal = "Current Opinion in Anaesthesiology",
issn = "0952-7907",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Anesthetic management of transcatheter aortic valve implantation

AU - Covello, Remo D.

AU - Landoni, Giovanni

AU - Zangrillo, Alberto

PY - 2011/8

Y1 - 2011/8

N2 - Purpose of Review: The revolution in transcatheter aortic valve implantation (TAVI) for the treatment of aortic stenosis has been well described by the large number of randomized trials, registries, and single and multicenter experiences published during 2010-2011. The aim of this review is to describe the challenges of the anesthetic management related to TAVI. Recent Findings: Recent data show that TAVI is clinically effective in patients with inoperable aortic stenosis when compared with standard therapy. It can be accomplished in high-risk patients with favorable outcomes compared with surgery as predicted by standard estimates of mortality and is associated with functional and hemodynamic improvement. Currently, TAVI is targeted at high-risk patients, but may be extended to lower risk groups in the near future. Outstanding questions concerning TAVI are related to its long-term durability and to procedural complications. Summary: Preprocedural, multidisciplinary assessment of the patient is essential prior to TAVI and should include a full anesthetic evaluation, consideration of patient comorbidities, and determination of technical feasibility. The role of scoring systems for risk prediction requires further scrutiny. Multidevice/multiple access approaches allow for treatment of a wide range of patients. Anesthetic techniques and supportive measures vary depending on procedural concerns, patient comorbidity, and severe, often unstable cardiac disease. Echocardiography is fundamental to preoperative evaluation, procedure guidance, and assessment of complications. Planned bailout strategies should be discussed with all members of the medical team. Postoperative standardized monitoring and management protocols are essential.

AB - Purpose of Review: The revolution in transcatheter aortic valve implantation (TAVI) for the treatment of aortic stenosis has been well described by the large number of randomized trials, registries, and single and multicenter experiences published during 2010-2011. The aim of this review is to describe the challenges of the anesthetic management related to TAVI. Recent Findings: Recent data show that TAVI is clinically effective in patients with inoperable aortic stenosis when compared with standard therapy. It can be accomplished in high-risk patients with favorable outcomes compared with surgery as predicted by standard estimates of mortality and is associated with functional and hemodynamic improvement. Currently, TAVI is targeted at high-risk patients, but may be extended to lower risk groups in the near future. Outstanding questions concerning TAVI are related to its long-term durability and to procedural complications. Summary: Preprocedural, multidisciplinary assessment of the patient is essential prior to TAVI and should include a full anesthetic evaluation, consideration of patient comorbidities, and determination of technical feasibility. The role of scoring systems for risk prediction requires further scrutiny. Multidevice/multiple access approaches allow for treatment of a wide range of patients. Anesthetic techniques and supportive measures vary depending on procedural concerns, patient comorbidity, and severe, often unstable cardiac disease. Echocardiography is fundamental to preoperative evaluation, procedure guidance, and assessment of complications. Planned bailout strategies should be discussed with all members of the medical team. Postoperative standardized monitoring and management protocols are essential.

KW - anesthesia

KW - aortic stenosis

KW - complications

KW - transcatheter aortic valve implantation

KW - transesophageal echocardiography

UR - http://www.scopus.com/inward/record.url?scp=79960697093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960697093&partnerID=8YFLogxK

U2 - 10.1097/ACO.0b013e328347f99f

DO - 10.1097/ACO.0b013e328347f99f

M3 - Article

C2 - 21602673

AN - SCOPUS:79960697093

VL - 24

SP - 417

EP - 425

JO - Current Opinion in Anaesthesiology

JF - Current Opinion in Anaesthesiology

SN - 0952-7907

IS - 4

ER -